PLEKHA7 and breast ductal adenocarcinoma: In addition, since PLEKHA7 immunolabeling is strongly decreased in poorly differentiated ductal carcinoma and undetectable in lobular carcinoma, where no tubules are formed, PLEKHA7 could be proposed as an additional marker, keeping in mind that lobular carcinoma is still best considered a morphological diagnosis [3].